← Leaderboards
Isabelle R. Lousada
Amyloidosis Research Consortium, Inc.
$113,692
Attributed
$113,692
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $49.3K · FY2021–25$50K$37.5K$25K$12.5K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$113,692 · 3
By mechanism
R13$113,692 · 3
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Elderly”
- Ted Ross · University Of Georgia$71,962,304
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Susan M Landau · University Of California Berkeley$47,252,026
- Olwen Hahn · Brigham And Women'S Hospital$30,838,934
- Jennifer Marie Suga · Kaiser Foundation Research Institute$25,722,415
- Badri N Vardarajan · University Of Miami School Of Medicine$24,132,011
Research focus
ElderlyResourcesPublic-Private PartnershipWorking GroupTherapy DevelopmentSeriesMeetingsNonprofit OrganizationsSystemic DiseaseUnited States Food And Drug AdministrationIndustryAmyloidosisDrug DevelopmentFutureAcademiaDesignCommunitiesCollaborationsFoundationsGovernmentAccelerationEfficacious TreatmentDisease ProgressionDiscipline
Grant awards (3)
The Amyloidosis Forum: Cross Stakeholder Working Group Projects to Accelerate Drug Development in AL and ATTR Amyloidosis$49,300
R13 · FY2025 · AG · contact PI
The Amyloidosis Forum: Advancing Drug Development in ATTR Amyloidosis in an Evolving Treatment Landscape.$40,000
R13 · FY2023 · AG · contact PI
Advancing Drug Development in AL Amyloidosis: Capitalizing Natural History and Assessing Endpoints$24,392
R13 · FY2021 · AG · contact PI